Role of Angiotensin II type 1 receptor on renal NAD(P)H oxidase, oxidative stress and inflammation in nitric oxide inhibition induced-hypertension

Life Sciences

Volumn 124, Issue , 2015, Pages 81-90

  Rincon J ^a   Correia, D ^b   Arcaya, J L ^a   Finol, E ^c   Fernandez A ^a   Perez M ^b   Yaguas, K ^b   Talavera, E ^b   Chavez M ^a   Summer, R ^d   Romero, F ^d  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

^b Centro de Investigaciones Biomédicas IVIC Zulia   (Venezuela)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

AT1R; Hypertension; IL 17; IL 6; L NAME; NADPH

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; GLYCOPROTEIN GP 91; INTERLEUKIN 17; INTERLEUKIN 6; LOSARTAN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROTEIN P22; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXIDOREDUCTASE; RENAL NAD(P)H OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HYPERTENSION; INFLAMMATION; LYMPHOCYTE; MACROPHAGE; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; UPREGULATION; ANIMAL; BLOOD PRESSURE; DRUG EFFECTS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPRAGUE DAWLEY RAT;

RATTUS;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOOD PRESSURE; HYPERTENSION; INFLAMMATION; INTERLEUKIN-17; INTERLEUKIN-6; LOSARTAN; MALE; NADH, NADPH OXIDOREDUCTASES; NF-KAPPA B; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; UP-REGULATION;

EID: 84922825991     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2015.01.005     Document Type: Article

References (62)

1. K.K. Griendling, M. Ushio-Fukai, B. Lassègue, and R.W. Alexander Angiotensin II signaling in vascular smooth muscle. New concepts Hypertension 29 1997 366 373
2. L.G. Navar, L.M. Harrison-Bernard, A. Nishiyama, and H. Kobori Regulation of intrarenal angiotensin II in hypertension Hypertension 39 2002 316 322
3. M. Ruiz-Ortega, V. Esteban, M. Ruperez, E. Sanchez-Lopez, J. Rodriguez-Vita, G. Carvajal, and J. Egido Renal and vascular hypertension-induced inflammation: role of angiotensin II Curr. Opin. Nephrol. Hypertens. 15 2006 159 166
4. J. Zhuo, K. Song, P.J. Harris, and F.A. Medelson In vitro autoradiography reveals predominantly AT1 angiotensin II receptors in rat kidney Ren. Physiol. Biochem. 15 1992 231 239
5. S.D. Crowley, S.B. Gurley, M.J. Herrera, P. Ruiz, R. Griffiths, A.P. Kumar, H.S. Kim, O. Smithies, T.H. Le, and T.M. Coffman Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney Proc. Natl. Acad. Sci. U. S. A. 103 2006 17985 17990
6. V. Reja, A.K. Goodchild, J.K. Phillips, and P.M. Pilowsky Upregulation of angiotensin AT1 receptor and intracellular kinase gene expression in hypertensive rats Clin. Exp. Pharmacol. Physiol. 33 2006 690 695
7. M. Khattab, M. Ahmad, O.A. Al-Shabanah, and M. Raza Effects of losartan on blood pressure, oxidative stress and nitrate/nitrite levels in the nitric oxide deficient hypertensive rats Recept. Channels 10 2004 147 157
8. M.T. Llinás, J.D. González, E. Nava, and F.J. Salazar Role of angiotensin II in the renal effects induced by nitric oxide and prostaglandin synthesis inhibition J. Am. Soc. Nephrol. 8 1997 543 550
9. S. Rajagopalan, S. Kurz, T. Münzel, M. Tarpey, B.A. Freeman, K.K. Griendling, and D.G. Harrison Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone J. Clin. Invest. 97 1996 1916 1923
10. J.D. Lambeth NOX enzymes and the biology of reactive oxygen Nat. Rev. Immunol. 4 2004 181 189
11. A. Sasche, and G. Wolf Angiotensin II-induced reactive oxygen species and the kidney J. Am. Soc. Nephrol. 18 2007 2439 2446
12. C.S. Wilcox Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am. J. Physiol. Regul. Integr. Comp. Physiol. 289 2005 913 935
13. B. Lassègue, and K.K. Griendling Reactive oxygen species in hypertension; an update Am. J. Hypertens. 17 2004 852 860
14. B.H. White, and A. Sidhu Increased oxidative stress in renal proximal tubules of the spontaneously hypertensive rat: a mechanism for defective dopamine D1A receptor/G-protein coupling J. Hypertens. 16 1998 1659 1665
15. A. Benigni, P. Cassis, and G. Remuzzi Angiotensin II revisited: new roles in inflammation, immunology and aging EMBO Mol. Med. 2 2010 247 257
16. C. Nataraj, M. Oliverio, R. Mannon, P. Mannon, L. Audoly, C. Amuchastegui, P. Ruiz, O. Smithies, and T. Coffman Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway J. Clin. Invest. 104 1999 1693 1701
17. B. Rodríguez-Iturbe, Y. Quiroz, M. Nava, L. Bonet, M. Chávez, J. Herrera-Acosta, R.J. Johnson, and H.A. Pons Reduction of renal immune infiltration results in blood pressure control in genetically hypertensive rats Am. J. Physiol. Ren. Physiol. 282 2002 191 201
18. Y. Quiroz, H. Pons, K.L. Gordon, J. Rincón, M. Chávez, G. Parra, J. Herrera-Acosta, D. Gómez-Garre, R. Largo, J. Egido, R.J. Johnson, and B. Rodríguez-Iturbe Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition Am. J. Physiol. Ren. Physiol. 281 2001 F38 F47
19. J. Herrera, A. Ferrebuz, E. Macgregor, and B. Rodriguez-Iturbe Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis J. Am. Soc. Nephrol. 17 2006 S218 S225
20. T.J. Guzik, N.E. Hoch, K.A. Brown, L.A. McCann, A. Rahman, S. Dikalov, J. Goronzy, C. Weyand, and D.G. Harrison Role of the T cell in the genesis of angiotensin II-induced hypertension and vascular dysfunction J. Exp. Med. 204 2007 2449 2460
21. D.L. Lee, L.C. Sturgis, H. Labazi, J.B. Osborne Jr., C. Fleming, J.S. Pollock, M. Manhiani, J.D. Imig, and M.W. Brands Angiotensin II hypertension is attenuated in interleukin-6 knockout mice Am. J. Physiol. Heart Circ. Physiol. 290 2006 935 940
22. B. Rodriguez-Iturbe, H. Pons, Y. Quiroz, K. Gordon, J. Rincón, M. Chávez, G. Parra, J. Herrera-Acosta, D. Gómez-Garre, R. Largo, J. Egido, and R.J. Johnson Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure Kidney Int. 59 2001 2222 2232
23. S.D. Crowley, C.W. Frey, S.K. Gould, R. Griffiths, P. Ruiz, J.L. Burchette, D.N. Howell, N. Makhanova, M. Yan, H.S. Kim, P.L. Tharaux, and T.M. Coffman Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension Am. J. Physiol. Ren. Physiol. 295 2008 515 524
24. K.J. Livak, and T.D. Schimittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(- delta delta C(T)) method Methods 25 2001 402 408
25. H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction Anal. Biochem. 95 1979 351 358
26. Y. Quiroz, A. Ferrebuz, F. Romero, N.D. Vaziri, and B. Rodríguez-iturbe Melatonin ameliorates oxidative stress, inflammation, proteinuria and progression of renal damage in rats with renal mass reduction Am. J. Physiol. Ren. Physiol. 294 2008 F336 F344
27. M. Sedlak, and R. Lindsay Estimation of total, protein-bound and non-protein sulfhydryl groups in tissue with Ellman's reagent Anal. Biochem. 25 1968 192 205
28. H. Aebi Catalase in vitro Methods Enzymol. 105 1982 121 126
29. A. Wendel Glutathione peroxidase Methods Enzymol. 77 1981 325 333
30. J.M. McCord Oxygen-derived free radicals in postischemic tissue injury N. Engl. J. Med. 312 1985 159 163
31. M. Ohsawa, K. Tamura, H. Wakui, A. Maeda, T. Dejima, T. Kanaoka, K. Azushima, K. Uneda, Y. Tsurumi-Ikeya, R. Kobayashi, M. Matsuda, S. Uchida, Y. Toya, H. Kobori, A. Nishiyama, A. Yamashita, Y. Ishikawa, and S. Umemura Deletion of the angiotensin II type 1 receptor-associated protein enhances renal sodium reabsorption and exacerbates angiotensin II-mediated hypertension Kidney Int. 86 2014 570 581
32. C.S. Wilcox Reactive oxygen species: roles in blood pressure and kidney function Curr. Hypertens. Rep. 4 2002 160 166
33. M. Araujo, and C.S. Wilcox Oxidative stress in hypertension: role of the kidney Antioxid. Redox Signal. 20 2014 74 101
34. J. Sainz, R. Wangensteen, I. Rodríguez Gómez, J.M. Moreno, V. Chamorro, A. Osuna, P. Bueno, and F. Vargas Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition Am. J. Hypertens. 18 2005 871 877
35. P.S. Gill, and C.S. Wilcox NADPH oxidases in the kidney Antioxid. Redox Signal. 8 2006 1597 1607
36. A.M. Garrido, and K.K. Griendling NADPH oxidases and angiotensin II receptor signaling Mol. Cell. Endocrinol. 29 2009 148 158
37. D.G. Harrison, and M.C. Gongora Oxidative stress and hypertension Med. Clin. North Am. 93 2009 621 635
38. N. Li, F.X. Yi, J.L. Spurrier, C.A. Bobrowitz, and A.P. Zou Production of superoxide through NADH oxidase in thick ascending limb of Henle's loop in rat kidney Am. J. Physiol. Ren. Physiol. 282 2002 1111 1119
39. Y. Taniyama, and K.K. Griendling Reactive oxygen species in the vasculature: molecular and cellular mechanisms Hypertension 42 2003 1075 1081
40. B. Lassègue, and R.E. Clempus Vascular NAD(P)H oxidases: specific features, expression, and regulation Am. J. Physiol. Regul. Integr. Comp. Physiol. 285 2003 277 297
41. Y. Quiroz, R.J. Johnson, and B. Rodriguez-Iturbe The role of T cells in the pathogenesis of primary hypertension Nephrol. Dial. Transplant. 27 Suppl. 4 2012 iv2 iv5
42. K.N. Brinson, A.A. Elmarakby, A.J. Tipton, G.R. Crislip, T. Yamamoto, B. Baban, and J.C. Sullivan Female SHR have greater blood pressure sensitivity and renal T cell infiltration following chronic NOS inhibition than males Am. J. Physiol. Regul. Integr. Comp. Physiol. 305 2013 701 710
43. M. Ruiz-Ortega, O. Lorenzo, M. Ruperez, S. Konig, B. Wittig, and J. Ejido Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms Circ. Res. 86 2000 1266 1272
44. M. Ruiz-Ortega, O. Lorenzo, M. Rupérez, Y. Suzuki, and J. Egido Angiotensin II activates nuclear transcription factor-kappaB in aorta of normal rats and in vascular smooth muscle cells of AT1 knockout mice Nephrol. Dial. Transplant. 16 Suppl. 1 2001 27 33
45. D.N. Muller, R. Dechend, E.M. Mervaala, J.K. Park, F. Schmidt, A. Fiebeler, J. Theuer, V. Breu, D. Ganten, H. Haller, and F.C. Luft NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats Hypertension 35 2000 193 201
46. K. Li, D. Guo, H. Zhu, K.S. Hering-Smith, L.L. Hamm, J. Ouyang, and Y. Dong Interleukin-6 stimulates epithelial sodium channels in mouse cortical collecting duct cells Am. J. Physiol. Regul. Integr. Comp. Physiol. 299 2010 590 595
47. M.W. Brands, A.K. Banes-Berceli, E.W. Inscho, H. Al-Azawi, A.J. Allen, and H. Labazi Interleukin 6 knockout prevents angiotensin II hypertension: role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation Hypertension 56 2010 879 884
48. B. Coles, C.A. Fielding, S. Rose-John, J. Scheller, S.A. Jones, and V.B. O'Donnell Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo Am. J. Pathol. 171 2007 315 325
49. E.V. Acosta-Rodríguez, G. Napolitani, A. Lanzavecchia, and F. Sallusto Interleukins 1 beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells Nat. Immunol. 8 2007 942 949
50. M. Veldhoen, R.J. Hocking, C.J. Atkins, R.M. Locksley, and B. Stockinger TGF-β in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17 producing T cells Immunity 24 2006 179 189
51. H17 lineage Nature 441 2006 231 234
52. J. Das, G. Ren, L. Zhang, A.I. Roberts, X. Zhao, A. Bothwell, L. Van Kaer, Y. Shi, and G. Das Transforming growth factor β is dispensable for the molecular orchestration of Th17 cell differentiation J. Exp. Med. 206 2009 2407 2416
53. M.S. Madhur, H.E. Lob, L.A. McCann, Y. Iwakura, Y. Blinder, T.J. Guzik, and D.G. Harrison Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction Hypertension 55 2010 500 507
54. T. Nomoto, T. Okada, K. Shimazaki, T. Yoshioka, M. Nonaka-Sarukawa, T. Ito, K. Takeuchi, K.I. Katsura, H. Mizukami, A. Kume, S. Ookawara, U. Ikeda, Y. Katayama, and K. Ozawa Systemic delivery of IL-10 by an AAV vector prevents vascular remodeling and end-organ damage in stroke-prone spontaneously hypertensive rats Gene Ther. 16 2009 383 391
55. M. Hermann, A. Flammer, and T.F. Luscher Nitric oxide in hypertension J. Clin. Hypertens. (Greenwich) 8 2006 17 29
56. W. Niedbala, B. Cai, and F.Y. Liew Role of nitric oxide in the regulation of T cell functions Ann. Rheum. Dis. 65 2006 iii37 iii40
57. K. Matrougui, Z. Abd Elmageed, M. Kassan, S. Choi, D. Nair, R.A. Gonzalez-Villalobos, A.A. Chentoufi, P. Kadowitz, S. Belmadani, and M. Partyka Natural regulatory T cells control coronary arteriolar endothelial dysfunction in hypertensive mice Am. J. Pathol. 178 2011 434 441
58. K.W. Moore, M.R. de Waal, R.L. Coffman, and A. O'Garra Interleukin-10 and the interleukin-10 receptor Annu. Rev. Immunol. 19 2001 683 765
59. T. Barhoumi, D.A. Kasal, M.W. Li, L. Shbat, P. Laurant, M.F. Neves, P. Paradis, and E.L. Schiffrin T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury Hypertension 57 2011 469 476
60. D.G. Harrison, T.J. Guzik, H.E. Lob, M.S. Madhur, P.J. Marvar, S.R. Thabet, A. Vinh, and C.M. Weyand Inflammation, immunity, and hypertension Hypertension 57 2011 132 140
61. M.G. Melaragno, and G.D. Fink Role of ANG II in hypertension produced by chronic inhibition of nitric oxide synthase in conscious rats Am. J. Physiol. 271 1996 806 811
62. Y.N. Nabah, T. Mateo, M. Cerdá-Nicolás, A. Alvarez, M. Martinez, A.C. Issekutz, and M.J. Sanz L-NAME induces direct arteriolar leukocyte adhesion, which is mainly mediated by angiotensin-II Microcirculation 12 2005 443 453